CCL4 and neoplasm: In the absence of this mechanism, (e.g. in tumours with an activated Wnt/β-catenin pathway leading to transcriptional repression of CCL-4 [111]), impaired trafficking and function of Batf3+ dependent CD8α+ DCs and a non-inflamed tumour immunophenotype are likely results.